Skip to main content
SpringerLink
Log in
Book cover

Oncological Surgical Pathology pp 871–917Cite as

Tumors of the Liver

  • Chapter
  • First Online:

  • 4502 Accesses

Abstract

This chapter deals with the gross, microscopic, immunohistochemical, ultrastructural, and molecular pathology features of benign and malignant gallbladder, extrahepatic bile ducts, and Vaterian system. Data on epidemiology, prognosis, and treatment options are also included.

The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views, opinions, or policies of the Uniformed Services University of the Health Sciences (USUHS), the Department of Defense (DoD), or the Departments of the Army, Navy, or Air Force. Mention of trade names, commercial products, or organizations does not imply endorsement by the US Government.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Rappaport AM. The structural and functional unit in the human liver (liver acinus). Anat Rec. 1958;130(4):673–89.

    PubMed  CAS  Google Scholar 

  2. Rappaport AM. Hepatic blood flow: morphologic aspects and physiology regulation. Int Rev Physiol. 1980;21:1–63.

    PubMed  CAS  Google Scholar 

  3. Peng H, Wisse E, Tian Z. Liver natural killer cells: subsets and roles in liver immunity. Cell Mol Immunol. 2016;13(3):328–36.

    PubMed  CAS  Google Scholar 

  4. Davidoff S, Kim S, Friedman B. von Meyenburg complexes (bile duct hamartomas). Clin Gastroenterol Hepatol. 2006;4:A26.

    Google Scholar 

  5. Redston MS, Wanless IR. The hepatic von Meyenburg complex: prevalence and association with hepatic and renal cysts among 2843 autopsies. Mod Pathol. 1996;9:233–7.

    PubMed  CAS  Google Scholar 

  6. Sinakos E, Papalavrentios L, Chourmouzi D, et al. The clinical presentation of Von Meyenburg complexes. Hippokratia. 2011;15(2):170–3.

    PubMed  PubMed Central  CAS  Google Scholar 

  7. Jain D, Ahrens W, Finkelstein S. Molecular evidence for the neoplastic potential of hepatic Von-Meyenburg complexes. Appl Immunohistochem Mol Morphol. 2010;18:166–71.

    PubMed  CAS  Google Scholar 

  8. Rogers TN, Woodley H, Ramsden W, et al. Solitary liver cysts in children: not always so simple. J Pediatr Surg. 2007;42(2):333–9.

    PubMed  Google Scholar 

  9. Bhathal PS, Hughes NR, Goodman ZD. The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol. 1996;20(7):858–64.

    PubMed  CAS  Google Scholar 

  10. Allaire GS, Rabin L, Ishak KG, Sesterhenn IA. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol. 1988;12:708–15.

    PubMed  CAS  Google Scholar 

  11. Wei J, Zhang D, Yang J, Xu C. Intrahepatic bile duct adenoma (peribiliary gland hamartoma): a case report and review of literature. Int J Clin Exp Pathol. 2015;8(5):5908–13.

    PubMed  PubMed Central  Google Scholar 

  12. Hughes NR, Goodman ZD, Bhathal PS. An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis. Am J Surg Pathol. 2010;34:1312–8.

    PubMed  Google Scholar 

  13. Albores-Saavedra J, Hoang MP, Murakata LA, et al. Atypical bile duct adenoma, clear cell type. Am J Surg Pathol. 2001;25:956–60.

    PubMed  CAS  Google Scholar 

  14. Wu WW, Gu M, Lu D. Cytopathologic, histopathologic, and immunohistochemical features of intrahepatic clear cell bile duct adenoma: a case report and review of the literature. Case Rep Pathol. 2014;2014:874826.

    PubMed  PubMed Central  Google Scholar 

  15. Roncalli M, Sciarra A, Tommaso LD. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. Clin Mol Hepatol. 2016;22(2):199–211.

    PubMed  PubMed Central  Google Scholar 

  16. Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol. 2013;2013:604860.

    PubMed  PubMed Central  Google Scholar 

  17. Sasaki M, Nakanuma Y. Overview of hepatocellular adenoma in Japan. Int J Hepatol. 2012;2012:648131.

    PubMed  PubMed Central  Google Scholar 

  18. Bühler H, Pirovino M, Akobiantz A, Altorfer J, Weitzel M, Maranta E, et al. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology. 1982;82:775–82.

    PubMed  Google Scholar 

  19. Lerut JP, Ciccarelli O, Sempoux C, Danse E, deFlandre J, Horsmans Y, et al. Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation. Transpl Int. 2003;16:879–84.

    PubMed  Google Scholar 

  20. Huurman VA, Schaapherder AF. Management of ruptured hepatocellular adenoma. Dig Surg. 2010;27:56–60.

    PubMed  Google Scholar 

  21. van Aalten SM, de Man RA, IJzermans JN, Terkivatan T. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg. 2012;99:911–6.

    PubMed  Google Scholar 

  22. Erdogan D, Busch OR, van Delden OM, Ten Kate FJ, Gouma DJ, van Gulik TM. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int. 2006;26:433–8.

    PubMed  Google Scholar 

  23. Noels JE, van Aalten SM, van der Windt DJ, Kok NF, de Man RA, Terkivatan T, et al. Management of hepatocellular adenoma during pregnancy. J Hepatol. 2011;54:553–8.

    PubMed  Google Scholar 

  24. Stoot JH, van Roosmalen J, Terpstra OT, Schaapherder AF. Life-threatening hemorrhage from adenomas in the liver during pregnancy. Dig Surg. 2006;23:155.

    PubMed  Google Scholar 

  25. Mathieu D, Vilgrain V, Mahfouz AE, Anglade MC, Vullierme MP, Denys A. Benign liver tumors. Magn Reson Imaging Clin N Am. 1997;5:255–88.

    PubMed  CAS  Google Scholar 

  26. Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR, et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol. 2009;16:640–8.

    PubMed  Google Scholar 

  27. Witjes CD, Ten Kate FJ, van Aalten SM, Dwarkasing RS, Willemssen FE, Verhoef C, et al. Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: a plea against. Gut. 2012;61:1645–6.

    PubMed  Google Scholar 

  28. Dhingra S, Fiel MI. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics. Arch Pathol Lab Med. 2014;138(8):1090–7.

    PubMed  Google Scholar 

  29. Nault JC, Bioulac-Sage P, Zucman-Rossi J. Hepatocellular benign tumors-from molecular classification to personalized clinical care. Gastroenterology. 2013;144:888–902.

    PubMed  CAS  Google Scholar 

  30. Bellamy CO, Maxwell RS, Prost S, Azodo IA, Powell JJ, Manning JR. The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre. Histopathology. 2013;62:431–45.

    PubMed  Google Scholar 

  31. Lagana SM, Salomao M, Bao F, Moreira RK, Lefkowitch JH, Remotti HE. Utility of an immunohistochemical panel consisting of glypican-3, heat shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. Appl Immunohistochem Mol Morphol. 2013;21:170–6.

    PubMed  Google Scholar 

  32. Nault JC, Zucman-Rossi J. TERT promoter mutations in primary liver tumors. Clin Res Hepatol Gastroenterol. 2016;40:9–14.

    PubMed  CAS  Google Scholar 

  33. Ronot M, Bahrami S, Calderaro J, Valla DC, Bedossa P, Belghiti J, et al. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011;53:1182–91.

    PubMed  Google Scholar 

  34. Sempoux C, Paradis V, Komuta M, Wee A, Calderaro J, Balabaud C, et al. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders. J Hepatol. 2015;63:1173–80.

    PubMed  CAS  Google Scholar 

  35. Chiche L, Dao T, Salamé E, Galais MP, Bouvard N, Schmutz G, et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg. 2000;231:74–81.

    PubMed  PubMed Central  CAS  Google Scholar 

  36. Whelan TJ, Baugh JH, Chandor S. Focal nodular hyperplasia of the liver. Ann Surg. 1973;177:150–8.

    PubMed  PubMed Central  Google Scholar 

  37. Mathieu D, Kobeiter H, Maison P, Rahmouni A, Cherqui D, Zafrani ES, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology. 2000;118:560–4.

    PubMed  CAS  Google Scholar 

  38. Bioulac-Sage P. Angiopoietines play a physiopathological role in focal nodular hyperplasia. Gastroenterol Clin Biol. 2004;28:200–1.

    PubMed  Google Scholar 

  39. Wanless IR, Albrecht S, Bilbao J, et al. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol. 1989;2(5):456–62.

    PubMed  CAS  Google Scholar 

  40. Scardapane A, Ficco M, Sabbà C, et al. Hepatic nodular regenerative lesions in patients with hereditary haemorrhagic telangiectasia: computed tomography and magnetic resonance findings. Radiol Med. 2013;118(1):1–13.

    PubMed  CAS  Google Scholar 

  41. Maetani Y, Itoh K, Egawa H, et al. Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar. Am J Roentgenol (AJR). 2002;178(4):869–75.

    Google Scholar 

  42. Paradis V, Laurent A, Flejou JF, Vidaud M, Bedossa P. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology. 1997;26:891–5.

    PubMed  CAS  Google Scholar 

  43. Wanless I, Sapp H, Guindi M. The pathogenesis of focal nodular hyperplasia: an hypothesis based on histologic review of 20 lesions including 3 occurring in early biliary cirrhosis. Hepatology. 2006;44:491A.

    Google Scholar 

  44. Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, et al. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol. 2008;49:61–71.

    PubMed  CAS  Google Scholar 

  45. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48:163–70.

    PubMed  CAS  Google Scholar 

  46. Bosch FX, Ribes J, Cléries R, Díaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9(2):191–211.

    PubMed  Google Scholar 

  47. Darbari A, Sabin KM, Shapiro CN, Schwarz KB. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology. 2003;38(3):560–6.

    PubMed  Google Scholar 

  48. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328(25):1797–801.

    PubMed  CAS  Google Scholar 

  49. Fitzmorris P, Singal AK. Surveillance and diagnosis of hepatocellular carcinoma. Gastroenterol Hepatol (N Y). 2015;11(1):38–46.

    Google Scholar 

  50. Trojan J, Zangos S, Schnitzbauer AA. Diagnostics and treatment of hepatocellular carcinoma in 2016: standards and developments. Visc Med. 2016;32(2):116–20.

    PubMed  PubMed Central  Google Scholar 

  51. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31(4):339–46.

    PubMed  CAS  Google Scholar 

  52. Terracciano L, Tornillo L. Cytogenetic alterations in liver cell tumors as detected by comparative genomic hybridization. Pathologica. 2003;95(2):71–82.

    PubMed  CAS  Google Scholar 

  53. Tornillo L, Carafa V, Richter J, et al. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas. J Pathol. 2000;192(3):307–12.

    PubMed  CAS  Google Scholar 

  54. Lee JS, Thorgeirsson SS. Genetic profiling of human hepatocellular carcinoma. Semin Liver Dis. 2005;25(2):125–32.

    PubMed  CAS  Google Scholar 

  55. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P, Zucman-Rossi J. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology. 2001;120(7):1763–73.

    PubMed  CAS  Google Scholar 

  56. Zondervan PE, Wink J, Alers JC, et al. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J Pathol. 2000;192(2):207–15.

    PubMed  CAS  Google Scholar 

  57. Niketeghad F, Decker HJ, Caselmann WH, et al. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer. 2001;85(5):697–704.

    PubMed  PubMed Central  CAS  Google Scholar 

  58. Tornillo L, Carafa V, Sauter G, et al. Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Investig. 2002;82(5):547–53.

    PubMed  CAS  Google Scholar 

  59. Wong N, Lai P, Lee SW, et al. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol. 1999;154(1):37–43.

    PubMed  PubMed Central  CAS  Google Scholar 

  60. Boige V, Laurent-Puig P, Fouchet P, et al. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res. 1997;57(10):1986–90.

    PubMed  CAS  Google Scholar 

  61. Kusano N, Shiraishi K, Kubo K, et al. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology. 1999;29(6):1858–62.

    PubMed  CAS  Google Scholar 

  62. Lerebours F, Olschwang S, Thuille B, et al. Fine deletion mapping of chromosome 8p in non-small-cell lung carcinoma. Int J Cancer. 1999;81(6):854–8.

    PubMed  CAS  Google Scholar 

  63. Nishida N, Nishimura T, Ito T, et al. Chromosomal instability and human hepatocarcinogenesis. Histol Histopathol. 2003;18(3):897–909.

    PubMed  CAS  Google Scholar 

  64. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336(26):1855–9.

    PubMed  CAS  Google Scholar 

  65. Chang MH, Shau WY, Chen CJ, et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA. 2000;284(23):3040–2.

    PubMed  CAS  Google Scholar 

  66. Yamashita S, Vauthey JN, Kaseb AO, et al. Prognosis of fibrolamellar carcinoma compared to non-cirrhotic conventional hepatocellular carcinoma. J Gastrointest Surg. 2016;20(10):1725–31.

    PubMed  Google Scholar 

  67. Riggle KM, Turnham R, Scott JD, et al. Fibrolamellar hepatocellular carcinoma: mechanistic distinction from adult hepatocellular carcinoma. Pediatr Blood Cancer. 2016;63(7):1163–7.

    PubMed  PubMed Central  Google Scholar 

  68. Sergi CM. Hepatocellular carcinoma, fibrolamellar variant: diagnostic pathologic criteria and molecular pathology update. A primer. Diagnostics (Basel). 2016;6(1):3–12

    Google Scholar 

  69. Honeyman JN, Simon EP, Robine N, et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science. 2014;343:1010–4.

    PubMed  PubMed Central  CAS  Google Scholar 

  70. Atienza LG, Berger J, Mei X, et al. Liver transplantation for fibrolamellar hepatocellular carcinoma: a national perspective. J Surg Oncol. 2016;115:319. https://doi.org/10.1002/jso.24515.

    Article  PubMed  Google Scholar 

  71. Kassahun WT. Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments. World J Surg Oncol. 2016;14(1):151.

    PubMed  PubMed Central  Google Scholar 

  72. Aronson DC, Meyers RL. Malignant tumors of the liver in children. Semin Pediatr Surg. 2016;25(5):265–75.

    PubMed  Google Scholar 

  73. Giardiello FM, Offerhaus GJ, Krush AJ, et al. Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr. 1991;119(5):766–8.

    PubMed  CAS  Google Scholar 

  74. Hamada Y, Takada K, Fukunaga S, Hioki K. Hepatoblastoma associated with Beckwith-Wiedemann syndrome and hemihypertrophy. Pediatr Surg Int. 2003;19(1–2):112–4.

    PubMed  CAS  Google Scholar 

  75. Krush AJ, Traboulsi EI, Offerhaus JA, et al. Hepatoblastoma, pigmented ocular fundus lesions and jaw lesions in Gardner syndrome. Am J Med Genet. 1988;29(2):323–32.

    PubMed  CAS  Google Scholar 

  76. Mussa A, Ferrero GB. Screening hepatoblastoma in Beckwith-Wiedemann syndrome: a complex issue. J Pediatr Hematol Oncol. 2015;37(8):627.

    PubMed  Google Scholar 

  77. Ozawa MG, Cooney T, Rangaswami A, Hazard FK. Synchronous hepatoblastoma, neuroblastoma, and cutaneous capillary hemangiomas: a case report. Pediatr Dev Pathol. 2016;19(1):74–9.

    PubMed  Google Scholar 

  78. Sumazin P, Chen Y, Treviño LR, et al. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology. 2016;65:104. https://doi.org/10.1002/hep.28888.

    Article  PubMed  CAS  Google Scholar 

  79. Buendia MA. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Med Pediatr Oncol. 2002;39(5):530–5.

    PubMed  Google Scholar 

  80. Curia MC, Zuckermann M, De Lellis L, et al. Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations. Mod Pathol. 2008;21(1):7–14.

    PubMed  CAS  Google Scholar 

  81. Czauderna P, Haeberle B, Hiyama E, et al. The Children’s Hepatic Tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer. 2016;52:92–101.

    PubMed  Google Scholar 

  82. Chablé-Montero F, Shah BSA, Montante-Montes de Oca D, Angeles-Ángeles A, Henson DE, Albores-Saavedra J. Thyroid-like cholangiocarcinoma of the liver: an unusual morphologic variant with follicular, trabecular and insular patterns. Ann Hepatol. 2012;11(6):961–5.

    PubMed  Google Scholar 

  83. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24(2):115–25.

    PubMed  Google Scholar 

  84. Khan SA, Emadossadaty S, Ladep NG, Thomas HC, Elliott P, Taylor-Robinson SD, Toledano MB. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol. 2012;56(4):848–54.

    PubMed  Google Scholar 

  85. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10.

    PubMed  PubMed Central  Google Scholar 

  86. Goodman ZD. Neoplasms of the liver. Mod Pathol. 2007;20(Suppl 1):S49–60.

    PubMed  Google Scholar 

  87. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the gallbladder, extrahepatic bile ducts and Vaterian system. Atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology. Fascicle 23; 2015.

    Google Scholar 

  88. Hall C, Mamlok V, Al-Khalil I. A sporadic case of advanced metastatic cholangiocarcinoma in a child: a case report and review of literature. J Pediatr Hematol Oncol. 2015;37(5):e333–5.

    PubMed  Google Scholar 

  89. Guglielmi A, Ruzzenente A, Campagnaro T, Nicoli P, Cappellani A, Malfermoni G, Iacono C. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg. 2009;33(6):1247–54.

    PubMed  Google Scholar 

  90. Lee SJ, Kwon W, Kang MJ, Jang JY, Chang YR, Jung W, Kim SW. Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma. Korean J Hepatobiliary Pancreat Surg. 2014;18(1):1–8.

    PubMed  PubMed Central  Google Scholar 

  91. Yeh CN, Wang SY, Chen YY, Chen MH, Chiang KC, Cheng CT, Tsai CY, Wang CC, Yeh TS, Chen TC. A prognostic nomogram for overall survival of patients after hepatectomy for intrahepatic cholangiocarcinoma. Anticancer Res. 2016;36(8):4249–58.

    PubMed  CAS  Google Scholar 

  92. Tan Y, Milikowski C, Toribio Y, et al. Intraductal papillary neoplasm of the bile ducts: a case report and literature review. World J Gastroenterol. 2015;21(43):12498–504.

    PubMed  PubMed Central  CAS  Google Scholar 

  93. Chu C, Felbel W, Chu F. Intrahepatic biliary intraductal oncocytic papillary neoplasm/carcinoma: first reported case in Australia and Literature Review. Radiol Case Rep. 2015;2(3):95.

    PubMed  PubMed Central  Google Scholar 

  94. Martin RC, Klimstra DS, Schwartz L, et al. Hepatic intraductal oncocytic papillary carcinoma. Cancer. 2002;95(10):2180–7.

    PubMed  Google Scholar 

  95. Sudo Y, Harada K, Tsuneyama K, Katayanagi K, Zen Y, Nakanuma Y. Oncocytic biliary cystadenocarcinoma is a form of intraductal oncocytic papillary neoplasm of the liver. Mod Pathol. 2001;14:1304–9.

    PubMed  CAS  Google Scholar 

  96. Wolf HK, Garcia JA, Bossen EH. Oncocytic differentiation in intrahepatic biliary cystadenocarcinoma. Mod Pathol. 1992;5:665–8.

    PubMed  CAS  Google Scholar 

  97. Albores-Saavedra J, Córdova-Ramón JC, Chablé-Montero F, Dorantes-Heredia R, Henson DE. Cystadenomas of the liver and extrahepatic bile ducts. Morphologic and immunohistochemical characterization of the biliary and intestinal variants. Ann Diagn Pathol. 2015;19(3):124–9.

    PubMed  Google Scholar 

  98. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the gallbladder, extrahepatic bile ducts and Vaterian system. In: Atlas of tumor pathology. 4th series, fascicle. Washington DC: American Registry of Pathology; 2015. p. 23.

    Google Scholar 

  99. Huang L, Li J, Zhou F, et al. Giant cystic lymphangioma of the liver. Hepatol Int. 2010;4(4):784–7.

    PubMed  PubMed Central  Google Scholar 

  100. Haratake J, Koide O, Takeshita H. Hepatic lymphangiomatosis: report of two cases, with an immunohistochemical study. Am J Gastroenterol. 1992;87(7):906–9.

    PubMed  CAS  Google Scholar 

  101. Van Steenbergen W, Joosten E, Marchal G, et al. Hepatic lymphangiomatosis. Report of a case and review of the literature. Gastroenterology. 1985;88(6):1968–72.

    PubMed  Google Scholar 

  102. Okano H, Shiraki K, Inoue H, et al. Natural course of cavernous hepatic hemangioma. Oncol Rep. 2001;8(2):411–4.

    PubMed  CAS  Google Scholar 

  103. Lanne JS, Dumortier J, Hervieu V, et al. Polycythemia and elevated serum erythropoietin associated with a liver haemangioma. Gastroenterol Clin Biol. 2010;34(11):629–32.

    PubMed  Google Scholar 

  104. Ishak KG, Goodman ZD, Stocker JT. Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology. 3rd series. Fascicle 31. Washington, D.C.: Armed Forces Institute of Pathology; 1999.

    Google Scholar 

  105. Mocchegiani F, Vincenzi P, Coletta M, et al. Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. Dig Liver Dis. 2016;48(3):309–14.

    PubMed  Google Scholar 

  106. Dail DH, Liebow AA. Intravascular bronchioloalveolar tumor. Am J Pathol. 1975;78:6a–7a.

    Google Scholar 

  107. Sardaro A, Bardoscia L, Petruzzelli MF, Portaluri M. Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor. Oncol Rev. 2014;8(2):259.

    PubMed  PubMed Central  Google Scholar 

  108. Hayashi Y, Inagaki K, Hirota S, et al. Epithelioid hemangioendothelioma with marked liver deformity and secondary Budd-Chiari syndrome: pathological and radiological correlation. Pathol Int. 1999;49(6):547–52.

    PubMed  CAS  Google Scholar 

  109. Mani H, Van Thiel DH. Mesenchymal tumors of the liver. Clin Liver Dis. 2001;5:219–57. viii

    PubMed  CAS  Google Scholar 

  110. Chaudhary P, Bhadana U, Singh RA, Ahuja A. Primary hepatic angiosarcoma. Eur J Surg Oncol. 2015;41(9):1137–43.

    PubMed  CAS  Google Scholar 

  111. Zhu YP, Chen YM, Matro E, et al. Primary hepatic angiosarcoma: a report of two cases and literature review. World J Gastroenterol. 2015;21(19):6088–96.

    PubMed  PubMed Central  Google Scholar 

  112. Falk H, Herbert J, Crowley S, Ishak KG, Thomas LB, Popper H, Caldwell GG. Epidemiology of hepatic angiosarcoma in the United States: 1964–1974. Environ Health Perspect. 1981;41:107–13.

    PubMed  PubMed Central  CAS  Google Scholar 

  113. Block JB. Angiosarcoma of the liver following vinyl chloride exposure. JAMA. 1974;229:53–4.

    PubMed  CAS  Google Scholar 

  114. Bioulac-Sage P, Laumonier H, Laurent C, Blanc JF, Balabaud C. Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis. 2008;28:302–14.

    PubMed  Google Scholar 

  115. Molina E, Hernandez A. Clinical manifestations of primary hepatic angiosarcoma. Dig Dis Sci. 2003;48:677–82.

    PubMed  Google Scholar 

  116. Cano-García F, Athie-Athie Ade J, García-Gómez JI, et al. Cystic angiosarcoma of the liver. A previously undescribed neoplasm. Ann Hepatol. 2016;15(2):283–6.

    PubMed  Google Scholar 

  117. Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS. 2014;28(4):453–65.

    PubMed  Google Scholar 

  118. Dittmer DP, Damania B. Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy. J Clin Invest. 2016;126(9):3165–75.

    PubMed  PubMed Central  Google Scholar 

  119. Rao SP, Bhagavath S, Chen CK, Tolete-Velcek F. Mesenchymal hamartoma of the liver in an older child: association with disseminated intravascular coagulation. Med Pediatr Oncol. 1984;12(2):112–5.

    PubMed  CAS  Google Scholar 

  120. Mack-Detlefsen B, Boemers TM, Groneck P, Bald R. Multiple hepatic mesenchymal hamartomas in a premature associated with placental mesenchymal dysplasia. J Pediatr Surg. 2011;46(8):e23–5.

    PubMed  Google Scholar 

  121. Cook JR, Pfeifer JD, Dehner LP. Mesenchymal hamartoma of the liver in the adult: association with distinct clinical features and histological changes. Hum Pathol. 2002;33(9):893–8.

    PubMed  Google Scholar 

  122. Qureshi SS, Bhagat M, Kembhavi S, et al. Benign liver tumors in children: outcomes after resection. Pediatr Surg Int. 2015;31(12):1145–9.

    PubMed  Google Scholar 

  123. Goodman ZD, Ishak KG. Angiomyolipoma of the liver. Am J Surg Pathol. 1984;8:745–50.

    PubMed  CAS  Google Scholar 

  124. Nonomura A, Enomoto Y, Takeda M, et al. Angiomyolipoma of the liver: a reappraisal of morphological features and delineation of new characteristic histological features from the clinicopathological findings of 55 tumours in 47 patients. Histopathology. 2012;61(5):863–80.

    PubMed  Google Scholar 

  125. Delgado R, de Leon Bojorge B, Albores-Saavedra J. Atypical angiomyolipoma of the kidney: a distinct morphologic variant that is easily confused with a variety of malignant neoplasms. Cancer. 1998;83(8):1581–92.

    PubMed  CAS  Google Scholar 

  126. Tsui WMS, Colombari C, Portmann BC, et al. Hepatic angiomyolipoma; a clinicopatholgic study of 30 cases and delineation of unusual morphologic variants. Am Surg Pathol. 1999;23:34–8.

    CAS  Google Scholar 

  127. Ashfaq R, Weinberg AG, Albores-Saavedra J. Renal angiomyolipomas and HMB-45 reactivity. Cancer. 1993;71(10):3091–7.

    PubMed  CAS  Google Scholar 

  128. Tsui WMS, Yuen AKT, Ma KF, Tse CCH. Hepatic angiomyolipoma with a deceptive trabecular pattern and HMB-45 reactivity. Histopathology. 1992;21:569–73.

    PubMed  CAS  Google Scholar 

  129. Monforte-Muñoz H, Kapoor N, Albores-Saavedra J. Epstein-Barr virus-associated leiomyomatosis and posttransplant lymphoproliferative disorder in a child with severe combined immunodeficiency: case report and review of the literature. Pediatr Dev Pathol. 2003;6(5):449–57.

    PubMed  Google Scholar 

  130. Vyas S, Psica A, Watkins J, Yu D, Davidson B. Primary hepatic leiomyoma: unusual cause of an intrahepatic mass. Ann Transl Med. 2015;3(5):73.

    PubMed  PubMed Central  Google Scholar 

  131. Luo XZ, Ming CS, Chen XP, Gong NQ. Epstein-Barr virus negative primary hepatic leiomyoma: case report and literature review. World J Gastroenterol. 2013;19(25):4094–8.

    PubMed  PubMed Central  Google Scholar 

  132. Omiyale AO. Primary leiomyoma of the liver: a review of a rare tumour. HPB Surg. 2014;2014:959202.

    PubMed  PubMed Central  Google Scholar 

  133. Wang ZS, Xu L, Ma L, et al. Hepatic falciform ligament clear cell myomelanocytic tumor: a case report and a comprehensive review of the literature on perivascular epithelioid cell tumors. BMC Cancer. 2015;15:1004.

    PubMed  PubMed Central  Google Scholar 

  134. Haji Ali R, Khalife M, El Nounou G, et al. Giant primary malignant mesothelioma of the liver: a case report. Int J Surg Case Rep. 2016;30:58–61.

    PubMed  PubMed Central  Google Scholar 

  135. Chablé-Montero F, Angeles-Ángeles A, Albores-Saavedra J. Inflammatory myofibroblastic tumor of the liver. Ann Hepatol. 2012;11(5):708–9.

    PubMed  Google Scholar 

  136. Schnelldorfer T, Chavin KD, Lin A, Lewin DN, Baliga PK. Inflammatory myofibroblastic tumor of the liver. J Hepato-Biliary-Pancreat Surg. 2007;14(4):421–3.

    Google Scholar 

  137. Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol. 2007;20(8):884–94.

    PubMed  Google Scholar 

  138. Dey B, Gochhait D, Kaushal G, et al. Solitary fibrous tumor of the liver: a rare tumor in a rarer location. Rare Tumors. 2016;8(3):6403.

    PubMed  PubMed Central  Google Scholar 

  139. Thway K, Ng W, Noujaim J, et al. The current status of solitary fibrous tumor: diagnostic features, variants, and genetics. Int J Surg Pathol. 2016;24(4):281–92.

    PubMed  CAS  Google Scholar 

  140. Silvanto A, Karanjia ND, Bagwan IN. Primary hepatic solitary fibrous tumor with histologically benign and malignant areas. Hepatobiliary Pancreat Dis Int. 2015;14(6):665–8.

    PubMed  Google Scholar 

  141. Beltrán MA. Solitary fibrous tumor of the liver: a review of the current knowledge and report of a new case. J Gastrointest Cancer. 2015;46(4):333–42.

    PubMed  Google Scholar 

  142. Teixeira F Jr, de Freitas Perina AL, de Oliveira Mendes G, et al. Fibrous solitary tumour of the liver. J Gastrointest Cancer. 2014;45(Suppl 1):216–7.

    PubMed  Google Scholar 

  143. Feng LH, Dong H, Zhu YY, Cong WM. An update on primary hepatic solitary fibrous tumor: an examination of the clinical and pathological features of four case studies and a literature review. Pathol Res Pract. 2015;211(12):911–7.

    PubMed  CAS  Google Scholar 

  144. Chi M, Dudek AZ, Wind KP. Primary hepatic leiomyosarcoma in adults: analysis of prognostic factors. Onkologie. 2012;35(4):210–4.

    PubMed  Google Scholar 

  145. Hasheminasab Zavareh R, Riahi Beni H, Iranpour A, et al. Leiomyosarcoma of inferior vena cava and right atrium with ascites and jaundice: a case report. Int J Hematol Oncol Stem Cell Res. 2016;10:232–5.

    PubMed  PubMed Central  Google Scholar 

  146. Ravaioli M, Serenari M, Cescon M, et al. Liver and Vena Cava En Bloc resection for an invasive Leiomyosarcoma causing Budd-Chiari syndrome, under Veno-Venous bypass and liver hypothermic perfusion : liver hypothermic perfusion and Veno-Venous bypass for inferior Vena Cava Leiomyosarcoma. Ann Surg Oncol. 2017;24(2):556–7.

    PubMed  Google Scholar 

  147. Jadhav SA, Atluri VS, Prajapati R, Satoskar RR. Leiomyosarcoma of inferior vena cava. J Postgrad Med. 2011;57(4):332–4.

    PubMed  CAS  Google Scholar 

  148. Shivathirthan N, Kita J, Iso Y, et al. Primary hepatic leiomyosarcoma: case report and literature review. World J Gastrointest Oncol. 2011;3(10):148–52.

    PubMed  PubMed Central  Google Scholar 

  149. Thapar PM, Mathur SK, Saksena DS, Shah HK. Leiomyosarcoma of inferior vein cava presenting as acute Budd-Chiari syndrome. Indian J Gastroenterol. 2001;20(1):33–5.

    PubMed  CAS  Google Scholar 

  150. Putra J, Ornvold K. Undifferentiated embryonal sarcoma of the liver: a concise review. Arch Pathol Lab Med. 2015;139(2):269–73.

    PubMed  Google Scholar 

  151. Sánchez-Aguilar AC, Díaz-Flores O, Albores-Saavedra J. Embryonal sarcoma of the liver in a young. Ann Hepatol. 2009;8(1):63.

    PubMed  Google Scholar 

  152. Schoofs G, Braeye L, Vanheste R, et al. Hepatic rhabdomyosarcoma in an adult: a rare primary malignant liver tumor. Case report and literature review. Acta Gastroenterol Belg. 2011;74(4):576–81.

    PubMed  CAS  Google Scholar 

  153. Reznichenko AA, Klingbeil LR, Shah SA. Giant primary yolk sac tumor of the liver. J Gastrointest Surg. 2016;20(9):1669–70.

    PubMed  Google Scholar 

  154. Jaffe ES, Nicolae A, Pittaluga S. Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls. Mod Pathol. 2013;26(Suppl 1):S71–87.

    PubMed  PubMed Central  CAS  Google Scholar 

  155. Shi Y, Wang E. Hepatosplenic T-cell lymphoma: a clinicopathologic review with an emphasis on diagnostic differentiation from other T-cell/natural killer-cell neoplasms. Arch Pathol Lab Med. 2015;139(9):1173–80.

    PubMed  CAS  Google Scholar 

  156. Calvaruso M, Gulino A, Buffa S, et al. Challenges and new prospects in hepatosplenic γδ T-cell lymphoma. Leuk Lymphoma. 2014;55(11):2457–65.

    PubMed  CAS  Google Scholar 

  157. Visnyei K, Grossbard ML, Shapira I. Hepatosplenic γδ T-cell lymphoma: an overview. Clin Lymphoma Myeloma Leuk. 2013;13(4):360–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Medica Sur Clinic and Foundation, National University of Mexico, School of Medicine, Mexico City, Mexico

    Jorge Albores-Saavedra

  2. Department of Preventative Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

    Donald E. Henson

  3. Department of Pathology, Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornel University, New York, NY, USA

    David S. Klimstra

Authors
  1. Jorge Albores-Saavedra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donald E. Henson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David S. Klimstra
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA

    Cesar A. Moran

  2. Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA

    Neda Kalhor

  3. Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA

    Annikka Weissferdt

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Albores-Saavedra, J., Henson, D.E., Klimstra, D.S. (2020). Tumors of the Liver. In: Moran, C.A., Kalhor, N., Weissferdt, A. (eds) Oncological Surgical Pathology . Springer, Cham. https://doi.org/10.1007/978-3-319-96681-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-96681-6_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-96680-9

  • Online ISBN: 978-3-319-96681-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation